top of page
Immune Materials Limited (IML) is revolutionizing public health with IMU+®, a groundbreaking antimicrobial technology. Founded in 2022 by Professor Chris Lo (盧君宇) and Professor CW Kan (簡志偉), IML delivers long-lasting antimicrobial solutions. IMU+® embeds organic antimicrobial agents into materials, forming a durable matrix that destroys 99.99% of pathogens on contact and provides over three years of eco-friendly protection. Based in Hong Kong, IML is expanding globally, actively seeking international clients and partnerships From healthcare to consumer goods, IML is reshaping safety standards worldwide to create safer, healthier environments. Join us in building a sustainable future.
bottom of page